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Elevated blood pressure is an important global health problem, and in-utero under-nutrition may be an important
factor in the pathogenesis of hypertension. In the present study, we tested the hypothesis that antenatal maternal
low protein diet (MLPD) leads to sexually dimorphic developmental programming of the components of the pulmonary
renin-angiotensin system. This may be important in the antenatal MLPD-associated development of hypertension. In
pregnant mice, we administered normal (control) and isocaloric 50 % protein restricted diet, commencing one week
before mating and continuing until delivery of the pups. From the 18th to 24th week postnatal, we measured blood
pressure in the offspring by use of a non-invasive tail-cuff method. In the same mice, we examined the mRNA and protein
expression of the key components of the pulmonary renin-angiotensin system. Also, we examined microRNA
complementary to angiotensin converting enzymes (ACE) 2 in the offspring lungs. Our results demonstrate that
as a consequence of antenatal MLPD: 1) pup birthweight was significantly reduced in both sexes. 2) female
offspring developed hypertension, but males did not. 3) In female offspring, ACE-2 protein expression was significantly
reduced without any change in the mRNA levels. 4) miRNA 429, which has a binding site on ACE-2 - 3’ UTR was
significantly upregulated in the female antenatal MLPD offspring. 5) In males, ACE-2 mRNA and protein expression
were unaltered. We conclude that in the mouse, antenatal MLPD-induced reduction of ACE-2 in the female offspring
lung may be an important mechanisms in sexually dimorphic programming of hypertension.
Keywords: Angiotensin converting enzyme, microRNA, Epigenetics, DOHaD, Fetal programming, Developmental
origins, Barker hypothesisBackground
More than 150 years after its first description, high blood
pressure has been listed as the primary cause of death of
61,005 Americans in 2008 (www.heart.org/statistics). In 90
to 95% of these cases, the cause of hypertension is not
known (AHA, 2008). Importantly, a family history of
hypertension is an important risk factor for its develop-
ment [1]; which suggests a strong genetic or familial envir-
onmental factor in its genesis. Moreover, during recent
years, accumulating evidence indicates that to a significant
degree, hypertension may have a developmental origin.
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cluding mice [3–6], rats [7], guinea pigs [8], and sheep [9],
have demonstrated the importance of maternal nutrition
during gestation in the genesis of hypertension in the
adult offspring.
In humans, evidence supports sexually dimorphic
trends in the occurrence of hypertension [10], with
males being more affected than females before the lat-
ter’s menopause; and males and females being affected
equally following female menopause [11]. Notably, with
increasing age the blood pressure in females increases
more rapidly than that of males [12]. The mechanisms
of these changes are not known, however.
Following the discovery of renin as a pressor molecule
[13], the renin-angiotensin system (RAS) has been estab-
lished as one of the major pathways involved in both the
development of hypertension and in fluid homeostasis.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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standing of this system has changed radically over the
past several decades. The cascade starts with an α2-
globulin angiotensinogen (AGT), which is produced
constitutively and released into the circulation, chiefly
by the liver. A substrate for renin (secreted by kidneys),
AGT is converted into the decapeptide angiotensin I
(Ang I), and subsequently by angiotensin converting en-
zyme 1 (ACE 1) to the octapeptide Ang II. By the action
of ACE-2, Ang II activity is terminated by its conversion
to Ang 1–7. Of note, both ACE-1 and ACE-2 are se-
creted by the lung [14]. Importantly, a number of drugs
(enalapril, lisinopril, etc.) used clinically [15–17] inhibit
ACE1 and underscore the role of lungs in hypertension.
Furthermore, studies have demonstrated that modula-
tion of ACE from the lungs have important implications
in the development of hypertension [18, 19]. Studies
from our laboratory [3–5] and others [20] have demon-
strated significant changes in the RAS in response to
antenatal MLPD. However, the extent to which antenatal
MLPD can lead to sexual dimorphic programing of the
RAS in association with hypertension is not known. Also,
the specific components of the RAS pathway that may be
important in this programing are not well understood.
Thus, we tested the hypothesis that antenatal MLPD leads
to sexually dimorphic developmental programming of the
components of the pulmonary renin-angiotensin system,
which may be important in the antenatal MLPD-associated
development of hypertension.Methods
Experimental animal and tissues
The present study was in compliance with the Animal Wel-
fare Act, guidelines of the American Physiological Society,
and was approved by the Institutional Animal Care and
Use Committee (IACUC) of Loma Linda University. We
have described all these methods in our previous publica-
tions [3–6]. Briefly, we obtained FVB/NJ mice (~8 weeks of
age) from Jackson Laboratories (Bar Harbor, ME), and
housed them in the Animal Research Facility, Loma Linda
University under conditions of 14 h light, 10 h darkness,
ambient temperature of 20 °C, and relative humidity of 30
to 60 %. At 16 weeks of age, the mice were bred, by keeping
the males and females together for 12 h (overnight). In the
morning, mating was confirmed by examination of vaginal
plugs, and considered 0.5 day post coitum (DPC). We
started the study with 16 animals in each group. However,
following overnight mating, the mice dams without vaginal
plug and significant weight gain on day 7 post coitum were
excluded from the study. This reduced the number of mice
dams to 8 to 10 dams in each group. Following birth, 8
pups per group from 8 different mice dams were used to
conduct the blood pressure measurement study. Molecularbiology study (real-time PCR) were conducted on 4 animals
from each group.
Protein deprivation
Protein restricted chow was obtained from Newco
Distributors Inc. (Rancho Cucamonga, CA). Mice dams
were divided in two groups: control protein diet (18 g/
100 g, 100 % protein content), and antenatal MLPD (9 g/
100 g, 50 % protein diet). To avoid the stress of food
change during gestation and to include the peri-
conceptual period, diet administration was started one
week before mating. To maintain an isocaloric diet with
low protein, we replaced the proteins with carbohydrates.
The normal diet contained 18 g protein/100 g food, as de-
scribed (additional file 1) [3–6]. We measured the amount
of food (g/day) consumed by the mice on both normal
and isocaloric low protein diets; and these were similar,
[being 3 ± 0.5 g for females (n = 16) and 4 ± 0.3 g for males
(n = 16) in the control group and 3 ± 0.4 (n = 16) for fe-
males and 4 ± 0.3 g for males (n = 16) in the antenatal
MLPD group, respectively].
Physiological Measurement
We measured body weight on the morning after the pups
were delivered (0.5 Days). Intact placentas were collected
from the cage and placental weight was determined. After
birth, all the mice dams were maintained on the control
diet to examine the effect of antenatal developmental
programming per se. Blood pressure was measured non-
invasively, weekly by determining the tail blood volume,
flow, and pressure with a volume pressure recording
sensor and an occlusion tail-cuff (CODA System, Kent
Scientific, Torrington, CT). This system is significantly dif-
ferent from the plethysmographic based tail-cuff measure-
ment system, which measures only systolic blood pressure
[21]. This is a highly accurate system with the capability of
measuring systolic and diastolic blood pressures with the
heart rate simultaneously and non-invasively [22, 23].
Moreover, in numerous other studies, the tail cuff method
has been shown to measure the blood pressure non-
invasively and accurately in mice and rats [24, 25]. Before
commencing our studies, mice were placed on a warming
plate at 37° centigrade until the temperature of the tail-
region measured 37° by an infrared thermometer. Follow-
ing the warming, the mice were trained for three 15-min
sessions each day for three days, or until we obtained stable
blood pressure recordings. Blood pressure was measured
20 times on a fixed day (Tuesday) and time (~11:30 AM),
once weekly from 18 to 24 weeks of age.
mRNA and protein quantification
At 32 weeks of age the mice were euthanized by cervical
dislocation and the lungs were isolated. The isolated lungs
were snap frozen in liquid nitrogen and stored at −80°
Table 1 Antibodies used in the study
No. Name Company Cat. No. Dilution
1 Angiotensinogen Swant Inc. Switzerland 138 1:1000
2 Renin Santa Cruz Biotechnologies sc-27320 1:300
3 ACE-1 Abcam Inc. ab39172 1:1000
4 ACE-2 Abcam Inc. ab59351 1:1000
5 AT-1 Abcam Inc. ab59018 1:250
6 AT-2 Abcam Inc. ab19134 1:250
7 GAPDH Abcam Inc. ab9485 1:2000
8 Alpha-Actin Abcam Inc. Ab1801 1:1000
9 ERK1/2 Cell Signaling Technology #9102 1:1000


















Goyal et al. BMC Physiology  (2015) 15:2 Page 3 of 8centigrade for later analysis. For each experiment lung tis-
sue from 4 different mice from different mothers were
used. Real-time PCR and western immunoblot assays were
conducted, as described and validated previously in our
laboratory [3–5]. We isolated and quantified RNA and
protein by Allprep DNA/RNA Mini Kit according to
the manufacturer’s instructions (Qiagen Inc, Valencia,
CA Cat # 80204). Isolated mRNA was analyzed using a
NanoDrop1000 Spectrophotometer (Thermo Scientific,
Waltham, MA) at 260/280 wavelength UV rays to check
for quality and quantity. The 260/280 ratio of 1.8 to 2
was accepted for quantification with real-time PCR.
Real-time PCR was performed on Light Cycler 1.5
































Fig. 1 Weight in grams (g) of mice offspring at birth, 4 weeks, and
32 weeks of age from control and antenatal MLPD group. *Denotes
P < 0.05. N = 16 for each group. MLPD - Mice offspring from the
maternal low protein diet groupprobes and primers, designed using the Universal Probe
Library, a web based software (Roche Inc.), and the Quant-
fast Real-Time PCR Kit (Qiagen). Total RNA (1 ug per
reaction) was reverse transcribed using Quantitect reverse
transcriptase kit (Qiagen, Valencia, CA). Relative expression
was normalized to 18S RNA and fold-changes were calcu-
lated using the ΔΔCt method with normalization of indi-
vidual PCR efficiencies [26].
Western-immunoblot experiments were conducted as
described previously [4, 5]. Briefly, frozen samples were ho-
mogenized in the 1 x cell lysing buffer (Cell Signaling
Technology, Beverly, MA) containing a 1× phosphatase
and protease inhibitor cocktail (Sigma). Nuclei and debris
were pelleted by centrifugation at 1000 × g for 10 min. The
supernatant was collected and stored at −80 °C. SDS-gel
and western blot were performed by using appropriate anti-
bodies (Table 1). All secondary antibodies were obtained
from Abcam (Cambridge, MA). Twenty μg protein from
each sample was loaded on a SDS-gel and electrophoresed
at 100 V for 3 h. Proteins were transferred to a nitrocellu-









































Fig. 2 Mean arterial blood pressure for 7 weeks (18 weeks to 24 weeks
of age) of male mice offspring (A) and female mice offspring (B) from
control and antenatal MLPD group. *Denotes P < 0.05. N = 8 for each
group. MLPD - Mice offspring from the maternal low protein
diet group
Fig. 3 Expression levels of ACE2. (A) Western blot analysis (B) mRNA analysis o
density value, an arbitrary unit. *Denotes P < 0.05. N = 4 for each group. MLPD -
Table 2 Protein levels of un-altered components of the pulmonary
renin-angiotensin system in response to antenatal maternal
low-protein diet
Gene Name Males Females
Protein Levels Protein Levels
Control MLPD Control MLPD
Renin 0.82 ± 0.07 0.92 ± 0.05 0.7 ± 0.1 0.7 ± 0.15
ACE1 0.94 ± 0.04 0.81 ± 0.03 0.28 ± 0.15 0.16 ± 0.01
AT1 0.15 ± 0.01 0.14 ± 0.03 0.19 ± 0.01 0.21 ± 0.03
AT2 0.08 ± 0.01 0.08 ± 0.02 0.1 ± 0.2 0.9 ± 0.02
Protein levels are shown as integrated density (arbitrary measurement) relative
to total-ERK. N = 4, no statistically significant difference (P < 0.05) was identified
by one way ANOVA and post-hoc Bonferroni’s in any of the measurement.
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luminescence using a ChemiImager (Alpha-Innotech,
San Leandro, CA). The results are expressed as fraction
of control. We performed control experiments with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
beta-tubulin, alpha-actin, and extracellular regulated
signal kinase1/2 (ERK1/2). Our results demonstrated
total ERK1/2 protein expression to be the most uniform
among all the four study groups. Moreover, ERK1/2 in-
tegrated density (arbitrary unit) on densitometry ana-
lysis correlated well with different amounts of protein
loaded, and was used as an internal control to account
for uniform protein loading.f mice offspring from control and antenatal MLPD groups. IDV - integrated



































Fig. 4 Expression levels of miR-429 from control and antenatal
MLPD groups. *Denotes P < 0.05. N = 4 for each group. MLPD - Mice
Offspring from the maternal low protein diet group
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MicroRNAs (miRNA) were identified for the 3’ UTR of
the ACE-2 mRNAs, using the web based bio-informatics
software – TargetScan 4.2 (http://www.targetscan.org).
Of 10 miRNA suggested by the bio-informatics software,
we chose mmu-mir-429 miRNA for the present study, by
the use of the Context Score of more than 90th percentile,
as described by Grimson et al. [27]. The identified miRNA
levels were measured by the use of Real-Time Taqman
microRNA PCR assays, according to manufacturer’s in-
structions (Life Technologies, Grand Island, NY).
Statistical analysis
We analyzed the data using repeated measure (RM)
two-way Univariate Analysis of Variance (ANOVA) with
Bonferroni’s and Tukey’s post-hoc analysis as well as lin-
ear and non-linear regression to determine statistically
significant differences between groups, by the use of
GraphPad Prism software (GraphPad Software Inc., San
Diego, CA) and IBM SPSS (IBM Corp., NY). The hy-
pothesis was accepted at P < 0.05. For the measurement
of blood pressure one male or female offspring was in-
cluded from one mice dam and considered n = 1.
Results
Offspring mice weight in response to antenatal protein
restriction
As a consequence of antenatal protein restriction during
the entire gestation, we observed a significant reduction in
birth weight in mice offspring. Both male and female ante-
natal MLPD were associated with a significant reduction
in the birth weight (Fig. 1A), being (g) for control male
1.5 ± 0.04 (n = 8), antenatal MLPD male 1.3 ± 0.04 (n =
11), control female 1.6 ± 0.05 (n = 8), and antenatal MLPD
female 1.2 ± 0.04 (n = 11). Of importance, the antenatal
MLPD offspring demonstrated catch-up growth, so that
by 32 weeks of age, female from the antenatal MLPD
group were significantly over-weight. Males were affected
to a significantly lesser degree, however (Fig. 1).
Litter size and placental weight
Neither litter size nor placental weights differ significantly.
The average litter size was 7 ± 2 and 6 ± 3 in the control
and antenatal MLPD group, respectively (P > 0.05). The
pups sex distribution was between 40 to 60 % per mice
dam between control and MLPD group (P > 0.05).
Blood pressure
We measured mean arterial blood pressure from the
18th week to 24th postnatal week (n = 8 mice in each
group). “A sexually dimorphic trend of hypertension was
observed in males and females as observed by a signifi-
cant interaction of Sex*Diet by two-way RM ANOVA”.
As shown in Fig. 2, the data demonstrates that antenatalMLPD female offspring had significantly higher mean ar-
terial blood pressure, compared to the offspring from
dams on the normal diet. In males, however, there was a
significantly less increase in mean arterial blood pressure
in response to antenatal MLPD, compared to females
(Fig. 2).
Renin angiotensin system expression
To examine the underlying molecular alterations in asso-
ciation with hypertension, we examined several key com-
ponents of the pulmonary renin-angiotensin system. With
antenatal MLPD, we observed no significant changes in
the protein expression of renin, ACE1, or angiotensin II
type 1 and 2 receptors protein expression (Table 2). Not-
ably, as shown in the Fig. 3A, in female antenatal MLPD
offspring, ACE-2 protein expression was significantly
reduced; whereas, no change was observed in the male off-
spring. To examine, the extent to which the alteration in
the ACE-2 expression occurs at the transcriptional level,
we conducted real-time PCR analysis of ACE-2 mRNA
(Fig. 3B). No significant changes were observed in ACE-2
mRNA levels in antenatal MLPD lungs from either males
or females.
ACE-2 complementary miRNA expression
To examine, whether the reduction in ACE-2 protein
levels in the female antenatal MLPD group is as a conse-
quence of reduced translation, we examined miRNA
miR-429, which has a complementary binding site on 3’
UTR of ACE-2. Of importance, as shown in Fig. 4 miR-
429 levels were significantly increased in the female and
decreased in maleantenatal MLPD lungs, compared to
controls.
Discussion
Accumulating evidence suggests that antenatal maternal
protein deprivation can lead to the development of
Goyal et al. BMC Physiology  (2015) 15:2 Page 6 of 8hypertension in the offspring [6, 7, 9, 28, 29]. Of note, in
a manner similar to humans, mice also show an increase
in blood pressure with aging [30]. The mechanisms of
this phenomenon are not known, however. In the
present study, we identified that in females, antenatal
MLPD-induced hypertension is associated with a reduc-
tion in the level of ACE-2 enzyme (Fig. 3). Importantly,
female mice offspring were affected with hypertension to
a significantly greater extent than males (Fig. 2), which
may relate to the ACE-2 gene being located on the X
chromosome [31]. Further, studies in three different rat
strains have demonstrated that reduced ACE-2 expres-
sion is associated with hypertension [32]. In addition,
ACE-2 gene maps to a defined quantitative trait locus
(QTL) for increased blood pressure on the X chromo-
some in these hypertensive rats [32].
Several other reports also have suggested an import-
ant role of ACE-2 in hypertension [33, 34]. In theFig. 5 Summarized findings of the studypresent study, as a consequence of antenatal MLPD, we
observed that ACE-2 was reduced only in female, and
not male offspring (Fig. 3A). Importantly, only female
offspring from the antenatal MLPD group were signifi-
cantly hypertensive (Fig. 2). It appears that, as a conse-
quence of antenatal MLPD, in females ACE-2 is
differentially regulated, and may play an important role
in the developmental programming of hypertension.
Being located on an X chromosome, ACE-2 gene is sus-
ceptible for sexually dimorphic programming, as the
chromosome is well known for other sexually dimorphic
gene expression and disorders [35]. Additionally, ACE-2 is
known to be regulated in a sexually dimorphic manner by
estrogen [36]. Also, a high fat diet in rats is known to
cause sexually dimorphic regulation of ACE-2 and the
development of hypertension [37]. The present study,
adds to the accumulating evidence that ACE-2 can be
developmentally programmed by antenatal stressors
Goyal et al. BMC Physiology  (2015) 15:2 Page 7 of 8during gestation, and may be a critical factor in the de-
velopment of hypertension.
Of vital importance, in the present study, we identified
that in response to antenatal MLPD, ACE-2 is not regu-
lated at the transcriptional level, but rather programming
occurs at the translational level. The ACE-2 mRNA levels
were not significantly altered as a consequence of ante-
natal maternal protein deprivation (Fig. 3B); however, the
ACE-2 protein levels were significantly lower in the ante-
natal MLPD females. Recent studies have demonstrated
that miRNA are important in post-translational gene regu-
lation, and play an important role in the developmental
programming of hypertension. miRNA can bind to the 3’
UTR of a near-complementary sequence of mRNA and
lead to reduced translation. As noted in Fig. 4, we ob-
served that miRNA 429, which is complementary to ACE-
2 was significantly upregulated, which agrees with other
studies [14, 38, 39]. Importantly, there was no increase in
ACE2 proteins and associated miRNA-429 in lungs from
the male MLPD group. As shown in the summary Fig. 5
and previous studies, we speculate that antenatal maternal
protein restriction leads to increased miR-429, which
causes reduced production of ACE-2 protein. Reduced
levels of ACE-2 lead to reduced degradation of the potent
vasoconstrictor angiotensin II and thus increased blood
pressure.
Conclusion
Developmental programming of adult health and disease
is an important factor in the genesis of hypertension.
The present study, demonstrates that sexual dimorphism
of the development of hypertension may be mediated
through miRNA-mediated mechanisms and alterations
in the ACE-2 gene. The questions remain, by what
mechanism miRNA expression is regulated and pro-
grammed by in-utero environment? What is the role of
estrogen in this signaling? We shall pursue thesein fu-
ture studies.
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